Trials / Sponsors / Wan-Guang Zhang
Wan-Guang Zhang
Academic / Other · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection Hepatocellular Carcinoma (HCC) | N/A | 2025-08-01 |
| Not Yet Recruiting | QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma HCC - Hepatocellular Carcinoma | Phase 1 | 2025-02-01 |
| Unknown | A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable M Macrotrabecular Massive Hepatocellular Carcinoma | Phase 2 | 2023-05-05 |
| Unknown | Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Adv Hepatocellular Carcinoma | Phase 1 | 2022-09-01 |